It's nice that there is a separate CC for NGIO. I would also have liked a CC to Generex for the so-called mother ship. With the $ 50 million funding mentioned in the news yesterday, I would have expected a higher PPS. But the market may seem to see NGIO and then GNBT differently. (still) Did any of you buy the $ 33 or $ 30 preference share?
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links